Introduction: A New Era in Genetic Innovation
CRISPR-Cas gene-editing technology has redefined genetic research, offering unparalleled precision in modifying DNA sequences. Often described as a “genetic scalpel,” this groundbreaking tool has opened doors to curing inherited diseases, enhancing agricultural resilience, and more. Yet, translating lab success into safe, effective therapies demands overcoming formidable scientific hurdles.
This article delves into the obstacles hindering CRISPR’s clinical adoption and highlights pioneering strategies—from chemical engineering to novel delivery systems—that are propelling gene editing into a future of limitless possibilities.
